VeriMomcordyceps sinensis mycelium extract est-il sûr pendant la grossesse ?
No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR safety assessment identifying reproductive or developmental toxicity for Cordyceps sinensis mycelium extract. Peer‑reviewed literature on Cordyceps reports bioactive constituents (e.g., cordycepin) with various pharmacologic effects, but no consistent animal or human reproductive/developmental toxicity data were identified to indicate a reproductive hazard. Dermal exposure from cosmetics may give low but measurable systemic exposure to small molecules in extracts (hence e=1). Sources consulted: ECHA Annex VI (no entry), PubMed, PubChem, CosIng, EWG.
Related ingredients
Frequently asked questions
- cordyceps sinensis mycelium extract est-il sûr pendant la grossesse ?
- No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR safety assessment identifying reproductive or developmental toxicity for Cordyceps sinensis mycelium extract. Peer‑reviewed literature on Cordyceps reports bioactive constituents (e.g., cordycepin) with various pharmacologic effects, but no consistent animal or human reproductive/developmental toxicity data were identified to indicate a reproductive hazard. Dermal exposure from cosmetics may give low but measurable systemic exposure to small molecules in extracts (hence e=1). Sources consulted: ECHA Annex VI (no entry), PubMed, PubChem, CosIng, EWG.
- cordyceps sinensis mycelium extract est-il sûr pendant l'allaitement ?
- No evidence from regulatory listings or authoritative safety assessments (CIR/SCCS/ECHA Annex VI) of transfer into breastmilk or lactation-specific toxicity. Mechanistic data indicating placental or milk transfer are lacking; therefore no mechanistic concern is assigned. Low but measurable systemic absorption is possible from topical use, so exposure to nursing mother is considered low (e=1). Sources: PubMed, PubChem, CosIng, ECHA Annex VI, EWG.
- cordyceps sinensis mycelium extract est-il sûr pour la peau de bébé ?
- No infant-specific reproductive or developmental toxicity data were identified and no regulatory flags for developmental toxicity exist. Mechanistic concerns for infant skin are not identified. Because infant skin has higher surface‑area‑to‑weight and a less mature barrier, exposure score is increased by +1 relative to adult (adult e=1 → baby e=2) to reflect higher potential per‑kg uptake from topical application of extracts containing small molecules. Sources: PubMed, PubChem, CosIng, ECHA Annex VI, EWG.
- Comment VeriMom évalue-t-il cordyceps sinensis mycelium extract ?
- VeriMom évalue cordyceps sinensis mycelium extract à 93/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à cordyceps sinensis mycelium extract pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à cordyceps sinensis mycelium extract basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.